18 active trials 14 recruiting 4 Phase 3 6 disease areas
| Phase 1 | 2 | |
| Phase 1/2 | 6 | |
| Phase 2 | 6 | |
| Phase 2/3 | 1 | |
| Phase 3 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07234162 | A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL… | Peripheral T-cell Lymphoma | Recruiting | 2026-06-08 |
| NCT07139873 | A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6) | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Recruiting | 2026-06-03 |
| NCT05668988 | A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or… | Non-small Cell Lung Cancer | Active, Not Recruiting | 2026-05-26 |
| Phase 2/3 | ||||
| NCT07712588 | Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma… | Diffuse Large B-Cell Lymphoma (DLBCL) | Not Yet Recruiting | 2026-08-05 |
| Phase 2 | ||||
| NCT07154264 | A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10) | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Recruiting | 2026-06-22 |
| NCT06539182 | DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8) | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Recruiting | 2026-06-02 |
| NCT07294365 | A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11) | Immune Thrombocytopenia (ITP) | Recruiting | 2026-01-22 |
| NCT06295432 | A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment… | Non-small Cell Lung Cancer | Recruiting | 2025-12-31 |
| NCT06276283 | DZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients… | Non-small Cell Lung Cancer | Recruiting | 2025-06-19 |
| NCT05712902 | Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion… | Non-Small Cell Lung Cancer | Active, Not Recruiting | 2024-12-30 |
| Phase 1/2 | ||||
| NCT07070440 | DZD6008 Combination Therapy in Patients With Locally Advanced or Metastatic NSCLC With… | Non Small Cell Lung Cancer | Recruiting | 2026-08-31 |
| NCT07079475 | Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have… | Non-Small Cell Lung Cancer | Recruiting | 2026-08-31 |
| NCT07496229 | Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib… | T-cell Lymphomas | Recruiting | 2026-04-17 |
| NCT07059650 | DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12) | Diffuse Large B-Cell Lymphoma | Recruiting | 2026-04-01 |
| NCT07328217 | A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | 2026-02-11 |
| NCT03974022 | Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small… | Non-Small Cell Lung Cancer | Active, Not Recruiting | 2026-01-29 |
| Phase 1 | ||||
| NCT06813365 | Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR… | Nonsmall-cell Lung Cancer | Recruiting | 2026-08-28 |
| NCT06905197 | A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have… | Non Small Cell Lung Cancer | Recruiting | 2026-02-27 |
Lung Cancer (9) · Non-Small Cell Lung Cancer (NSCLC) (9) · Non-Hodgkin Lymphoma (4) · Chronic Lymphocytic Leukemia (CLL) (3) · Leukemia (3) · DLBCL (2)